Endovastec(SH:688016) Shang Hai Zheng Quan Bao·2025-10-28 23:26Group 1 - The company approved a second phase of share repurchase plan, allowing for the repurchase of shares at a price not exceeding RMB 180 per share, with a total repurchase amount between RMB 100 million and RMB 200 million [2] - The maximum repurchase price was adjusted to RMB 178.35 per share after the 2024 semi-annual profit distribution, and further adjustments were made to RMB 178.01 and RMB 176.73 per share following subsequent profit distributions [3] - The company completed the share repurchase on October 27, 2025, acquiring a total of 1,333,943 shares, which represents 1.08% of the total share capital, at an average price of RMB 105.03 per share, totaling approximately RMB 140.1 million [4] Group 2 - The repurchased shares will be used for employee stock ownership plans or equity incentives, with all shares expected to be utilized within three years from the announcement date [6] - The company confirmed that there were no stock trades by directors, supervisors, and major shareholders during the repurchase period [5] - The repurchased shares will not enjoy rights such as profit distribution or voting rights until they are used, and if not utilized within the specified period, the company will proceed with capital reduction procedures [6]